已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A Sequential Method of Epidermal Growth Factor Receptor Mutation Detection Reduces False Negatives: A New Case With Doublet Mutations of L833V and H835L in China

医学 表皮生长因子受体 突变 吉非替尼 突变试验 遗传学 癌症研究 内科学 基因 癌症 生物
作者
Yuan Zhuang,Jingjing Xu,Haitao Ma,Weidong Zhu,Linchuan Guo,Suya Kang,Feng Guo
出处
期刊:Clinical Lung Cancer [Elsevier BV]
卷期号:14 (3): 295-300 被引量:12
标识
DOI:10.1016/j.cllc.2012.11.003
摘要

Clinical Practice Points •Screening for epidermal growth factor receptor (EGFR) mutation before choosing a therapeutic strategy for patients with advanced non–small-cell lung cancer (NSCLC) is universally accepted at present. One of the reasons that certain patients without activating EGFR mutation respond to EGFR–tyrosine kinase inhibitor (TKI) treatment is possibly due to false-negative EGFR mutation. However, none of the available methods can provide the entire information of EGFR mutation; while maintaining the best sensitivity and specificity. Rare mutations are often evasive due to the limitation of screening methods. •Here, we present a case that can be easily missed due to the chosen method for EGFR mutation detection. The common activating and resistance-related EGFR mutations were all absent from the amplification refractory mutation system assay. Direct DNA sequencing, however, detected complex EGFR mutations of L833V and H835L in EGFR exon 21; therefore, the exact status of EGFR mutation cannot be provided only by a single method. •We report here, to our knowledge, the seventh case in the world and the second case in mainland China of doublet EGFR mutations of L833V and H835L in EGFR exon 21. Albeit rare, this specific type of EGFR mutation deserves more attention because it is related to a good response to EGFR-TKI therapy. To reduce the frequency of false negatives, hence not to lose any opportunities for a potential EGFR-TKI treatment, a sequential workflow by using amplification refractory mutation system assay and/or direct sequencing for EGFR mutation examination according to the specimen quality and quantity (tumor load and DNA yield) is proposed. •Screening for epidermal growth factor receptor (EGFR) mutation before choosing a therapeutic strategy for patients with advanced non–small-cell lung cancer (NSCLC) is universally accepted at present. One of the reasons that certain patients without activating EGFR mutation respond to EGFR–tyrosine kinase inhibitor (TKI) treatment is possibly due to false-negative EGFR mutation. However, none of the available methods can provide the entire information of EGFR mutation; while maintaining the best sensitivity and specificity. Rare mutations are often evasive due to the limitation of screening methods. •Here, we present a case that can be easily missed due to the chosen method for EGFR mutation detection. The common activating and resistance-related EGFR mutations were all absent from the amplification refractory mutation system assay. Direct DNA sequencing, however, detected complex EGFR mutations of L833V and H835L in EGFR exon 21; therefore, the exact status of EGFR mutation cannot be provided only by a single method. •We report here, to our knowledge, the seventh case in the world and the second case in mainland China of doublet EGFR mutations of L833V and H835L in EGFR exon 21. Albeit rare, this specific type of EGFR mutation deserves more attention because it is related to a good response to EGFR-TKI therapy. To reduce the frequency of false negatives, hence not to lose any opportunities for a potential EGFR-TKI treatment, a sequential workflow by using amplification refractory mutation system assay and/or direct sequencing for EGFR mutation examination according to the specimen quality and quantity (tumor load and DNA yield) is proposed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
huohuo2完成签到,获得积分10
1秒前
顺心惜文完成签到 ,获得积分10
1秒前
1秒前
walamobo完成签到,获得积分10
4秒前
huo完成签到,获得积分10
4秒前
5秒前
璐璐发布了新的文献求助10
5秒前
酷波er的应助被阔达的冰露采纳,获得10
6秒前
6秒前
无心的冰绿完成签到 ,获得积分10
7秒前
活力傲柏完成签到,获得积分10
7秒前
7秒前
7秒前
xx2026发布了新的文献求助30
8秒前
xiaoyu完成签到 ,获得积分10
8秒前
阴暗蘑菇完成签到 ,获得积分10
8秒前
huo完成签到,获得积分10
8秒前
9秒前
木子完成签到,获得积分10
9秒前
aaaaassss完成签到,获得积分10
9秒前
10秒前
日尧发布了新的文献求助10
10秒前
11秒前
11秒前
聪明甜桃完成签到,获得积分10
11秒前
Lee完成签到 ,获得积分10
12秒前
传奇3的应助被勤劳的瑀采纳,获得10
12秒前
Kossy.NG完成签到 ,获得积分10
13秒前
人老多情完成签到,获得积分20
13秒前
huo完成签到,获得积分10
13秒前
kk完成签到,获得积分10
14秒前
14秒前
杜仕丽完成签到 ,获得积分10
14秒前
人生何处不青山完成签到,获得积分10
14秒前
惜缘完成签到 ,获得积分10
15秒前
16秒前
all_star发布了新的文献求助10
16秒前
huohuo完成签到,获得积分10
17秒前
人老多情发布了新的文献求助30
17秒前
听寒完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194853
求助须知:如何正确求助?哪些是违规求助? 9580564
关于积分的说明 21871986
捐赠科研通 7794485
什么是DOI,文献DOI怎么找? 3437769
关于科研通互助平台的介绍 2561095
邀请新用户注册赠送积分活动 2484486